Qualigen Therapeutics Dividends
| QLGN Stock | USD 4.62 0.04 0.86% |
As of the 30th of November 2024, Dividend Yield is likely to grow to 0.000001, while Dividends Paid is likely to drop about 2.4 M. Qualigen Therapeutics' past performance could be the main factor of why investors trade Qualigen Therapeutics stock today. Investors should clearly understand every aspect of the Qualigen Therapeutics dividend schedule, including its future sustainability, and how it might impact an overall investment strategy. This tool is helpful to digest Qualigen Therapeutics' dividend schedule and payout information. Qualigen Therapeutics dividends can also provide a clue to the current valuation of Qualigen Therapeutics.
| Last Reported | Projected for Next Year | ||
| Dividends Paid | 3.3 M | 2.4 M | |
| Dividend Paid And Capex Coverage Ratio | (37.36) | (39.23) |
Qualigen |
Investing in stocks that pay dividends is one of many strategies that are good for long-term investments. Ex-dividend dates are significant because investors in Qualigen Therapeutics must own a stock before its ex-dividend date to receive its next dividend.
Qualigen Therapeutics Dividends Paid Over Time
Today, most investors in Qualigen Therapeutics Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Qualigen Therapeutics' growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's dividends paid growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Qualigen Therapeutics dividends paid as a starting point in their analysis.
The total amount of dividends that a company has paid out to its shareholders over a specific period. Dividends Paid |
| Timeline |
Qualigen Therapeutics Historical Dividend Yield Growth
A solid dividend growth pattern of Qualigen Therapeutics could indicate future dividend growth is likely, which can signal long-term profitability for Qualigen Therapeutics. When investors calculate the dividend yield growth rate, they can use any interval of time they wish. They may also calculate the dividend yield growth rate using the least-squares method or simply take an annualized figure over a given time period. Dividend Yield is Qualigen Therapeutics dividend as a percentage of Qualigen Therapeutics stock price. Qualigen Therapeutics dividend yield is a measure of Qualigen Therapeutics stock productivity, which can be interpreted as interest rate earned on an Qualigen Therapeutics investment. A financial ratio that shows how much a company pays out in dividends each year relative to its stock price, calculated as annual dividends per share divided by price per share. Dividend Yield |
| Timeline |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Qualigen Therapeutics. If investors know Qualigen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Qualigen Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share 3.6 K | Revenue Per Share 1.034 | Quarterly Revenue Growth 0.137 | Return On Assets (0.75) | Return On Equity (8.42) |
The market value of Qualigen Therapeutics is measured differently than its book value, which is the value of Qualigen that is recorded on the company's balance sheet. Investors also form their own opinion of Qualigen Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Qualigen Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Qualigen Therapeutics' market value can be influenced by many factors that don't directly affect Qualigen Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Qualigen Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Qualigen Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Qualigen Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.